Lv1
8 积分 2023-12-04 加入
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
9天前
已完结
Neoantigens Elicit Protumorigenic Immune Responses in Pancreatic Cancer
12天前
已完结
Personalized Cancer Vaccine Approach Safe in Early Trial
25天前
已关闭
PGV001, a multi-peptide personalized neoantigen vaccine platform: Phase I study in patients with solid and hematological malignancies in the adjuvant setting
25天前
已完结
Disease diagnostics using machine learning of B cell and T cell receptor sequences
1个月前
已完结
Eliminating METTL1‐mediated accumulation of PMN‐MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation
2个月前
已完结
Nanoparticle-mediated enhancement of DNA Vaccines: Revolutionizing immunization strategies
2个月前
已完结
Vaccine development using artificial intelligence and machine learning: A review
2个月前
已完结
Bioinformatics for Cancer Immunotherapy
4个月前
已完结
Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
4个月前
已完结
皖公网安备34019202002308
